Post Profile






Proposition 61 is the wrong solution to the problem of high drug prices

Blatant price-gouging by EpiPen-maker Mylan and other pharmaceutical companies has stoked public outrage about the high cost of prescription drugs. Meanwhile, the emergence of a new class of exceptionally expensive specialty drugs has caused budget nightmares for state governments. But in California,...
read more

share

Related Posts


People are furious about the price of the EpiPen — here's how much it's increased in the last decade

Business & Finance : Business Insider: Clusterstock

There's an uproar over the price of the anaphylaxis treatment EpiPen, with lawmakers and politicians including Democratic presidential nominee Hillary Clinton blasting the drug's maker, Mylan Pharmaceuticals. In light of the outrage...

The maker of the EpiPen is being investigated for antitrust violations in New York (MYL)

Business & Finance : Business Insider: Clusterstock

Anger over high drug prices has put EpiPen maker Mylan in the news recently, but the company is now being investigated over another potential issue altogether. The price of the EpiPen, a device used in emergencies to treat severe al...

How Congress Can Make Drug Pricing More Rational

Business & Finance : Forbes: Business

The public reproach over the price of Mylan’s lifesaving drug EpiPen is the latest imbroglio in a much broader debate over drug costs. At issue is the rising list price on drugs. But as Mylan argued, these high reported prices often...

The Mylan CEO's senator father backs away from drug price discussions (MYL)

Business & Finance : Business Insider: Money Game

The pharmaceutical company Mylan has been in the hot seat with members of Congress over the price of the EpiPen. The device, used in emergencies to treat severe allergic reactions, costs more than 500% more than it did when Mylan ac...

EpiPen price gouging demonstrates need for more competition in generic drugs

Issues & Causes / Environmentalism : Greenspace

In the latest in a recent series of controversies over prescription drug prices, Mylan Pharmaceuticals has come under well-deserved fire for jacking up the price of a package of EpiPens — devices that deliver an emergency shot of ep...

Comments


Copyright © 2016 Regator, LLC